Skip to main content

Israel Molina Romero

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Israel Molina Romero

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Llicenciat en Medicina per la UAB. Adjunt del Servei de Malalties Infeccioses Hospital Universitari Vall d'Hebron. Responsable de la Unitat de Medicina Tropical i Salut Internacional de l'Hospital Vall d'Hebron. Director del Programa de Salut Internacional de l'ICS. Experiència clínica i de recerca a Guinea Ecuatorial, Brasil i Angola.

Projects

Red de Investigación Cooperativa en Enfermedades Tropicales RICET

IP: Israel Molina Romero
Collaborators: Jose Santos Santiago, Antoni Soriano Arandes, Diana Pou Ciruelo, Begoña Treviño Maruri, Nuria Serre Delcor, Fernando M Salvador Velez, Augusto Cesar Sao Aviles, Jordi Gómez i Prat, Raisa Morales Martinez, Red de Investigación Cooperativa en Enfermedades Tropicales RICET, Elena Sulleiro Igual
Funding agency: Instituto de Salud Carlos III
Funding: 143525
Reference: RD12/0018/0020
Duration: 01/01/2013 - 30/09/2017

Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas disease (BERENICE) Grant Agreement nº 305937

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Núria Pérez Picazo, Fernando M Salvador Velez, Esperanza Esteban Serna, Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas disease (BERENICE) Grant Agreement nº 305937, Elena Sulleiro Igual, Olga Sánchez- Maroto Carrizo
Funding agency: EUROPEAN COMMISSION
Funding: 939958.88
Reference: BERENICE_I.MOLINA_FP7_2012
Duration: 01/09/2012 - 31/08/2018

Estudio prospectivo para el cribado de la infección tuberculosa latente en población inmigrante mediante la prueba de la tuberculina y Quantiferon

IP: Israel Molina Romero
Collaborators: Jose Angel Rodrigo Pendás, Begoña Treviño Maruri, Fernando M Salvador Velez, Mª Teresa Tórtola Fernández, Estudio prospectivo para el cribado de la infección tuberculosa latente en población inmigrante mediante la prueba de la tubercu, Estudio prospectivo para el cribado de la infección tuberculosa latente en población inmigrante mediante la prueba de la tubercu
Funding agency: Instituto de Salud Carlos III
Funding: 35392.5
Reference: PI11/01503
Duration: 01/01/2012 - 30/06/2016

iNTER Support Action (International Network of Teleconsultation Excellence & Referral (iSA) Grant Agreement nº 223610

IP: Israel Molina Romero
Collaborators: Vicenç Falcó Ferrer
Funding agency: EUROPEAN COMMISSION
Funding: 33590
Reference: ISA 223610 FP7 HEALTH 2007
Duration: 01/09/2009 - 29/02/2012

Related news

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The DETECTIVE doctoral network, coordinated by the University of Turku and funded by the Marie Skłodowska-Curie Actions of the Horizon Europe programme, will train 14 predoctoral researchers in five countries.

The initiative focuses on awareness, prevention, and the normalization of sexual health check-ups among young people.

Related professionals

Giacomoluciano Vitelli

Giacomoluciano Vitelli

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Carmen Larramendi Hernández

Carmen Larramendi Hernández

Research technician
Kidney Physiopathology
Read more
Sergio Torres Dominguez

Sergio Torres Dominguez

Gestió i Administració
Fundraising Unit
Communication Directorate
Read more
Olga Fernandez Redo

Olga Fernandez Redo

Gestió i Administració
Fundraising Unit
Communication Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.